THEMISMEDNSEThemis Medicare Limited· PharmaceuticalsHighNeutral
Announced Thu, 13 Nov · 13:24 IST

Themis Medicare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.

THEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Themis Medicare Limited has submitted its financial results for the half-year ended September 30, 2025 (H1 FY26) to the stock exchange. The filing covers the company's performance over the six-month period, though specific revenue, profit, and margin figures were not included in the headline text provided. This is a routine regulatory disclosure required of listed companies under SEBI's listing obligations. Investors will need to review the full results document for detailed financial metrics and segment-wise performance.

Likely market impact

This is a standard compliance filing and on its own is unlikely to move the stock sharply. Shareholders should look at the detailed results for actual revenue, PAT, and margin trends versus prior periods to assess the company's underlying business performance.